NuraLogix researchers announce AI models that can predict Blood Biomarker Risk
TORONTO, Aug. 31, 2022 /PRNewswire/ — Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have
Read MoreTORONTO, Aug. 31, 2022 /PRNewswire/ — Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have
Read MoreNEW YORK, March 16, 2022 /PRNewswire/ — Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of
Read More